Source disclosure: February 06, 2026

Mochida Pharmaceutical Co., Ltd. [4534.T]

TOKYO, Feb 06 (Pulse News Wire) – Mochida Pharmaceutical Co., Ltd. (4534) has revised its FY2026/3 Full-Year consolidated earnings forecast. FORECAST REVISION SUMMARY: (Unit: ) Revenue Op Profit Ord Profit Net Profit Previous Forecast (A) - - - - Revised Forecast (B) 236 5 2 3 Change (B-A) 5 2 3 3,000 Change (%): Revenue +45.0% | OP +35.0% | OrdP +46.7% | NP +556.0% REASON FOR REVISION:

AI-translated content. 🟡 Confidence: Standard See termsOriginal filing

💬 Help us improve translation quality
Notice any errors in this article? Let us know with one click.
🎁 Report 3+ errors with your email and get a free month of premium access